Processa Pharmaceuticals / GlobeNewswire · Jul 2025
Confirmed the Intact option remained a key strategic partnership and reiterated the potential milestone and royalty economics.
Smart gels for local drug delivery to the gut
Company research
Public company, workplace, funding, and market signals
Overview
Clinical-stage biopharmaceutical company developing localized GI drug-delivery therapies built around a thermosensitive hydrogel / smart-gel platform to improve retention, local concentration, and reduce systemic exposure.
Primary product
INT-102 thermosensitive hydrogel (smart-gel) platform for localized GI drug delivery
Founded
2015
Headquarters
2627 Hanover Street, Palo Alto, CA 94304, United States
Team size
1-10
Industry
Pharmaceutical Manufacturing
Sub-industry
Biopharmaceuticals; drug delivery
Offices
2627 Hanover Street, Palo Alto, CA 94304, United States
Open Positions
0 jobs at Intact Therapeutics
No open positions
Check back later for new openings